Hoyoung Huh insider trades

Open-market stock purchases and sales by Hoyoung Huh, Director at Pliant Therapeutics, Inc, from SEC Form 4 filings since Apr 21, 2010.

Recent trades

DateStockTradeValue
Jun 11, 2026PLRX Pliant Therapeutics, IncBought (not open market)—
Dec 16, 2025AKTX Akari Therapeutics plcBought$250K
Dec 16, 2025AKTX Akari Therapeutics plcBought$1.2M

Companies traded

  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
  • AKTX Akari Therapeutics plc: 2 buys, last Dec 16, 2025
  • PKBO Peak Bio, Inc: 18 buys, last Nov 14, 2024
  • EIDX Eidos Therapeutics, Inc: other filings, last Jun 22, 2018
  • CTMX CytomX Therapeutics, Inc: other filings, last Jun 13, 2018
  • GERN Geron Corp: other filings, last May 15, 2018
  • ANTB AntriaBio, Inc: other filings, last Oct 31, 2016
  • FACT Facet Biotech Corp: other filings, last Apr 21, 2010

Get free alerts when Hoyoung Huh files a new trade →